GT Biopharma
GTBP
GTBP
35 hedge funds and large institutions have $4.36M invested in GT Biopharma in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 15 closing their positions.
Holders
35
Holders Change
-13
Holders Change %
-27.08%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
15
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
E
1
Ergoteles
New York
|
$0 |
| 2 |
2
Renaissance Technologies
New York
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$5K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$0 |
| 5 |
5
Millennium Management
New York
|
$271K |